Epigenetic associations of type 2 diabetes and BMI in an Arab population

[1]  A. Hofman,et al.  Disease variants alter transcription factor levels and methylation of their binding sites , 2016, Nature Genetics.

[2]  C. Ling,et al.  Epigenetic Alterations in Human Liver From Subjects With Type 2 Diabetes in Parallel With Reduced Folate Levels. , 2015, The Journal of clinical endocrinology and metabolism.

[3]  J. Houmard,et al.  Differential epigenetic and transcriptional response of the skeletal muscle carnitine palmitoyltransferase 1B (CPT1B) gene to lipid exposure with obesity. , 2015, American journal of physiology. Endocrinology and metabolism.

[4]  C. Ling,et al.  Does epigenetic dysregulation of pancreatic islets contribute to impaired insulin secretion and type 2 diabetes? , 2015, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[5]  E. Demerath,et al.  Epigenome-wide association study (EWAS) of BMI, BMI change and waist circumference in African American adults identifies multiple replicated loci. , 2015, Human molecular genetics.

[6]  Tom R. Gaunt,et al.  Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. , 2015, The lancet. Diabetes & endocrinology.

[7]  L. Almasy,et al.  Novel epigenetic determinants of type 2 diabetes in Mexican-American families. , 2015, Human molecular genetics.

[8]  T. Hansen,et al.  Impact of age, BMI and HbA1c levels on the genome-wide DNA methylation and mRNA expression patterns in human adipose tissue and identification of epigenetic biomarkers in blood. , 2015, Human molecular genetics.

[9]  J. Houmard,et al.  Lipid exposure elicits differential responses in gene expression and DNA methylation in primary human skeletal muscle cells from severely obese women. , 2015, Physiological genomics.

[10]  E. Hoffman,et al.  An analysis of DNA methylation in human adipose tissue reveals differential modification of obesity genes before and after gastric bypass and weight loss , 2015, Genome Biology.

[11]  Wadha A. Al Muftah,et al.  Association of DNA methylation with age, gender, and smoking in an Arab population , 2015, Clinical Epigenetics.

[12]  G. Bray,et al.  A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW study. , 2015, The Journal of clinical endocrinology and metabolism.

[13]  K. Suhre,et al.  Evaluation of SNP calling using single and multiple-sample calling algorithms by validation against array base genotyping and Mendelian inheritance , 2014, BMC Research Notes.

[14]  Nilesh J Samani,et al.  Cigarette smoking reduces DNA methylation levels at multiple genomic loci but the effect is partially reversible upon cessation , 2014, Epigenetics.

[15]  M. S. Almén,et al.  Genome-wide analysis reveals DNA methylation markers that vary with both age and obesity. , 2014, Gene.

[16]  L. Liang,et al.  Epigenome-Wide Association Study of Fasting Blood Lipids in the Genetics of Lipid-Lowering Drugs and Diet Network Study , 2014, Circulation.

[17]  C. Gieger,et al.  DNA methylation and body-mass index: a genome-wide analysis , 2014, The Lancet.

[18]  Rafael A. Irizarry,et al.  Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays , 2014, Bioinform..

[19]  C. Ling,et al.  Altered DNA Methylation and Differential Expression of Genes Influencing Metabolism and Inflammation in Adipose Tissue From Subjects With Type 2 Diabetes , 2014, Diabetes.

[20]  Elin Hall,et al.  Genome-Wide DNA Methylation Analysis of Human Pancreatic Islets from Type 2 Diabetic and Non-Diabetic Donors Identifies Candidate Genes That Influence Insulin Secretion , 2014, PLoS genetics.

[21]  A. Depaoli-Roach,et al.  Sterol Regulatory Element-binding Protein-1 (SREBP-1) Is Required to Regulate Glycogen Synthesis and Gluconeogenic Gene Expression in Mouse Liver* , 2014, The Journal of Biological Chemistry.

[22]  Christian Gieger,et al.  Biomarkers for Type 2 Diabetes and Impaired Fasting Glucose Using a Nontargeted Metabolomics Approach , 2013, Diabetes.

[23]  Christian Gieger,et al.  Epigenetics meets metabolomics: an epigenome-wide association study with blood serum metabolic traits , 2013, Human molecular genetics.

[24]  Gabi Kastenmüller,et al.  Early Metabolic Markers of the Development of Dysglycemia and Type 2 Diabetes and Their Physiological Significance , 2013, Diabetes.

[25]  Alireza Moayyeri,et al.  COHORT PROFILE Cohort Profile : TwinsUK and Healthy Ageing Twin Study , 2013 .

[26]  T. Scully.  Diabetes in numbers , 2012, Nature.

[27]  Devin C. Koestler,et al.  DNA methylation arrays as surrogate measures of cell mixture distribution , 2012, BMC Bioinformatics.

[28]  G. Chrousos,et al.  Genome wide analysis reveals association of a FTO gene variant with epigenetic changes. , 2012, Genomics.

[29]  Matthieu Defrance,et al.  DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients , 2012, The EMBO journal.

[30]  Dvir Aran,et al.  Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. , 2012, Human molecular genetics.

[31]  J. Zou,et al.  Association of two polymorphisms within and near SOCS3 gene with obesity in three nationalities in Xinjiang province of China , 2011, Acta Pharmacologica Sinica.

[32]  Huidong Shi,et al.  Obesity related methylation changes in DNA of peripheral blood leukocytes , 2010, BMC medicine.

[33]  Ian M. Morison,et al.  Integrated Genetic and Epigenetic Analysis Identifies Haplotype-Specific Methylation in the FTO Type 2 Diabetes and Obesity Susceptibility Locus , 2010, PloS one.

[34]  Christian Gieger,et al.  Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting , 2010, PloS one.

[35]  Martin J. Aryee,et al.  Personalized Epigenomic Signatures That Are Stable Over Time and Covary with Body Mass Index , 2010, Science Translational Medicine.

[36]  Andrea Natali,et al.  α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population , 2010, PloS one.

[37]  Reedik Mägi,et al.  GWAMA: software for genome-wide association meta-analysis , 2010, BMC Bioinformatics.

[38]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[39]  J. Zierath,et al.  Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. , 2009, Cell metabolism.

[40]  C. Bouchard,et al.  Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. , 2009, The Lancet. Oncology.

[41]  J. Norris,et al.  Polymorphisms near SOCS3 are associated with obesity and glucose homeostasis traits in Hispanic Americans from the Insulin Resistance Atherosclerosis Family Study , 2009, Human Genetics.

[42]  P. Froguel,et al.  Lack of association between the Pro12Ala polymorphism of the PPAR-γ2 gene and type 2 diabetes mellitus in the Qatari consanguineous population , 2008, Acta Diabetologica.

[43]  L. Groop,et al.  Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion , 2008, Diabetologia.

[44]  Allan Vaag,et al.  TXNIP Regulates Peripheral Glucose Metabolism in Humans , 2007, PLoS medicine.

[45]  C. Kahn,et al.  Suppressor of Cytokine Signaling 1 (SOCS-1) and SOCS-3 Cause Insulin Resistance through Inhibition of Tyrosine Phosphorylation of Insulin Receptor Substrate Proteins by Discrete Mechanisms , 2005, Molecular and Cellular Biology.

[46]  J. Flier,et al.  Suppressor of Cytokine Signaling 3 Is a Physiological Regulator of Adipocyte Insulin Signaling* , 2004, Journal of Biological Chemistry.

[47]  C. Kahn,et al.  Suppressor of Cytokine Signaling 1 (SOCS-1) and SOCS-3 Cause Insulin Resistance through Inhibition of Tyrosine Phosphorylation of Insulin Receptor Substrate Proteins by Discrete Mechanisms , 2004, Molecular and Cellular Biology.

[48]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[49]  A. Bird,et al.  Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals , 2003, Nature Genetics.

[50]  M. White,et al.  SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2* , 2002, The Journal of Biological Chemistry.

[51]  John D. Storey.  A direct approach to false discovery rates , 2002 .

[52]  B. Roe,et al.  DQX1, an RNA-dependent ATPase homolog with a novel DEAQ box: expression pattern and genomic sequence comparison of the human and mouse genes , 2001, Mammalian Genome.

[53]  E. Van Obberghen,et al.  SOCS-3 Is an Insulin-induced Negative Regulator of Insulin Signaling* , 2000, The Journal of Biological Chemistry.

[54]  J. Flier,et al.  The Role of SOCS-3 in Leptin Signaling and Leptin Resistance* , 1999, The Journal of Biological Chemistry.

[55]  J. Flier,et al.  Identification of SOCS-3 as a potential mediator of central leptin resistance. , 1998, Molecular cell.

[56]  A. Razin,et al.  Distribution of 5-methylcytosine in chromatin. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[57]  M. Kibuuka.  KING'S COLLEGE, LONDON , 1932, British medical journal.

[58]  Judy H. Cho,et al.  Finding the missing heritability of complex , 2009 .

[59]  M de Lange,et al.  Are Twins and Singletons Comparable? A Study of Disease-related and Lifestyle Characteristics in Adult Women , 2001, Twin Research.

[60]  Arthur D. Riggs,et al.  X inactivation, differentiation, and DNA methylation. , 1975, Cytogenetics and cell genetics.